Effects of s-propargyl-cysteine (sprc) in caerulein-induced acute pancreatitis in mice

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Sidhapuriwala, Jenab N ^a   Hegde, Akhil ^b   Ang, Abel D ^b   Zhu, Yi Zhun ^a,c   Bhatia, Madhav ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ANTIINFLAMMATORY AGENT; CERULETIDE; DISTILLED WATER; HYDROGEN SULFIDE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; S PROPARGYL CYSTEINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER; CYSTEINE; CYTOKINE; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE; S PROPARGYLCYSTEINE; S-PROPARGYLCYSTEINE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IN VIVO STUDY; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PANCREAS; PNEUMONIA; PROTECTION; TISSUE LEVEL; ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; GAS; INFLAMMATION; LUNG; METABOLISM; METHODOLOGY; PANCREATITIS; PATHOLOGY; TIME;

MUS;

ACUTE DISEASE; AMYLASES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAERULEIN; CYSTEINE; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASES; HYDROGEN SULFIDE; INFLAMMATION; LUNG; MALE; MICE; PANCREAS; PANCREATITIS; PEROXIDASE; TIME FACTORS;

EID: 84863229950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032574     Document Type: Article

References (37)

1. Łowicka E, Bełtowski J, (2007) Hydrogen sulfide (H2S)- the third gas of interest for pharmacologists. Pharmacol Rep 59: 4-24.
2. Szabó C, (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935.
3. Bos EM, Leuvenink HG, Snijder PM, Kloosterhuis NJ, Hillebrands JL, et al. (2009) Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 20: 1901-1905.
4. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, et al. (2009) Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg 138: 977-984.
5. Spiller F, Orrico MI, Nascimento DC, Czaikoski PG, Souto FO, et al. (2010) Hydrogen sulfide improves neutrophil migration and survival in sepsis via K+ATP channel activation. Am J Respir Crit Care Med 182: 360-368.
6. Bhatia M, Sidhapuriwala J, Moochhala SM, Moore PK, (2005) Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat. Br J Pharmacol 145: 141-144.
7. Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM, et al. (2005) Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J 19: 623-625.
8. Collin M, Anuar FB, Murch O, Bhatia M, Moore PK, et al. (2005) Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol 146: 498-505.
9. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, et al. (2005) Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 19: 1196-1198.
10. Mok YY, Atan MS, Yoke Ping C, Zhong Jing W, Bhatia M, et al. (2004) Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol 143: 881-889.
11. Zhang H, Zhi L, Moore PK, Bhatia M, (2006) Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 290: L1193-L1201.
12. Sidhapuriwala J, Li L, Sparatore A, Bhatia M, Moore PK, (2007) Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat. Eur J Pharmacol 569: 149-154.
13. Bhatia M, Sidhapuriwala JN, Sparatore A, Moore PK, (2008) Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury. Shock 29: 84-88.
14. Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P, et al. (2007) Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 42: 706-719.
15. Li L, Salto-Tellez M, Tan CH, Whiteman M, Moore PK, (2009) GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic Biol Med 47: 103-113.
16. Fiorucci S, Orlandi S, Mencarelli A, Caliendo G, Santagada V, et al. (2007) Enhanced activity of a hydrogen sulphide releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol 150: 996-1002.
17. Esechie A, Kiss L, Olah G, Horváth EM, Hawkins H, et al. (2008) Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation. Clin Sci (Lond) 115: 91-97.
18. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, et al. (2009) Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 31: 267-274.
19. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, et al. (2005) Pathophysiology of acute pancreatitis. Pancreatology 5: 132-144.
20. Tonsi AF, Bacchion M, Crippa S, Malleo G, Bassi C, (2009) Acute pancreatitis at the beginning of the 21st century: the state of the art. World J Gastroenterol 15: 2945-2959.
21. Bang UC, Semb S, Nojgaard C, Bendtsen F, (2008) Pharmacological approach to acute pancreatitis. World J Gastroenterol 14: 2968-2976.
22. Sidhapuriwala JN, Ng SW, Bhatia M, (2009) Effects of hydrogen sulfide on inflammation in caerulein-induced acute pancreatitis. J Inflamm (Lond) 6: 35.
23. Wang Q, Liu HR, Mu Q, Rose P, Zhu YZ, (2009) S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. J Cardiovasc Pharmacol 54: 139-146.
24. Amagase H, (2006) Clarifying the real bioactive constituents of garlic. J Nutr 136: 716S-725S.
25. Mizuguchi S, Takemura S, Minamiyama Y, Kodai S, Tsukioka T, et al. (2006) S-allyl cysteine attenuated CCl4-induced oxidative stress and pulmonary fibrosis in rats. Biofactors 26: 81-92.
26. Kodai S, Takemura S, Minamiyama Y, Hai S, Yamamoto S, et al. (2007) S-allyl cysteine prevents CCl(4) induced acute liver injury in rats. Free Radic Res 41: 489-497.
27. Chuah SC, Moore PK, Zhu YZ, (2007) S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. Am J Physiol Heart Circ Physiol 293: H2693-H2701.
28. Wang Q, Wang XL, Liu HR, Rose P, Zhu YZ, (2010) Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production. Antioxid Redox Signal 12: 1155-1165.
29. Frossard JL, Saluja AK, Mach N, Lee HS, Bhagat L, et al. (2002) In vivo evidence for the role of GM-CSF as a mediator in acute pancreatitis associated lung injury. Am J Physiol Lung Cell Mol Physiol 283: L541-L548.
30. Labarca C, Paigen K, (1980) A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344-352.
31. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, et al. (2000) Inflammatory mediators in acute pancreatitis. J Pathol 190: 117-125.
32. Escobar J, Pereda J, Arduini A, Sandoval J, Sabater L, et al. (2009) Cross-talk between oxidative stress and pro-inflammatory cytokines in acute pancreatitis: a key role for protein phosphatases. Curr Pharm Des 15: 3027-3042.
33. Shanmugam MK, Bhatia M, (2010) The role of pro-inflammatory molecules and pharmacological agents in acute pancreatitis and sepsis. Inflamm Allergy Drug Targets 9: 20-31.
34. Chooklin S, Pereyaslov A, Bihalskyy I, (2009) Pathogenic role of myeloperoxidase in acute pancreatitis. Hepatobiliary Pancreat Dis Int 8: 627-631.
35. Minter RM, Ferry MA, Murday ME, Tannahill CL, Bahjat FR, et al. (2001) Adenoviral delivery of human and viral IL-10 in murine sepsis. J Immunol 167: 1053-1059.
36. Devière J, Le Moine O, Van Laethem JL, Eisendrath P, Ghilain A, et al. (2001) Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 120: 498-505.
37. Sherman S, Cheng CL, Costamagna G, Binmoeller KF, Puespoek A, et al. (2009) Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk. Pancreas 38: 267-274.